Revenue
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.4M | $644,294 | $2.1M | $0 | $3.1M | $136,566 | $12.0M | $0 | $0 | $1.4M | $17.4M | $3.9M | $2.7M | $10.9M | $144,650 | $443,011 |
| Research & development | $311,086 | $303,546 | $91,235 | $195,811 | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $4.3M | $8.0M | $7.4M | $6.7M | $6.2M | $6.2M | $7.9M | $7.3M | $8.7M | $9.7M | $11.9M | $5.3M | $6.3M | $8.5M | $3.8M | $4.9M |
| Operating income | $4.3M | −$7.3M | −$5.3M | −$6.7M | — | — | — | — | — | — | — | — | — | $2.4M | −$3.6M | −$4.4M |
| Operating margin | 26.56% | −1,134.62% | −246.21% | — | — | — | — | — | — | — | — | — | — | 21.99% | −2,506.38% | −1,003.16% |
| EBITDA | $617,324 | −$6.4M | −$3.5M | −$4.9M | — | — | — | — | — | — | — | — | — | $2.5M | −$3.5M | −$4.3M |
| EBITDA margin | 3.78% | −999.57% | −164.58% | — | — | — | — | — | — | — | — | — | — | 23.14% | −2,395.44% | −966.12% |
| Net income | −$2.3M | −$9.1M | −$5.5M | −$6.7M | −$3.1M | −$6.0M | $3.8M | −$7.0M | — | — | — | — | — | $2.1M | −$3.6M | −$4.5M |
| Net profit margin | −14.17% | −1,408.91% | −254.05% | — | −99.67% | −4,414.15% | 31.69% | — | — | — | — | — | — | 18.86% | −2,478.12% | −1,005.04% |
| Basic EPSper basic share | -CA$0.02 | -CA$0.12 | -CA$0.07 | -CA$0.10 | -CA$0.05 | -CA$0.09 | CA$0.06 | -CA$0.11 | -CA$0.16 | -CA$0.17 | CA$0.22 | -CA$0.04 | -CA$0.13 | CA$0.05 | -CA$0.10 | -CA$0.14 |
| Diluted EPSper diluted share | -CA$0.02 | -CA$0.12 | -CA$0.07 | -CA$0.10 | -CA$0.05 | -CA$0.09 | CA$0.06 | -CA$0.11 | -CA$0.16 | -CA$0.17 | CA$0.21 | -CA$0.04 | -CA$0.13 | CA$0.04 | -CA$0.10 | -CA$0.14 |
Reported shareholders